This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
AGLE (AEGLEA BIOTHERAPEUTICS INC) is held by 0 institutional investors as of Q3 2023.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer